Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource^®, LLC.

 

This activity is supported by an educational grant from Mallinckrodt Pharmaceuticals.

Credit Available

• Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
• Nurses — 0.5 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is directed toward health care providers serving patients with cirrhosis, including hepatologists, gastroenterologists, nephrologists, critical care specialists, physician assistants, and nurses. Other health care professionals will also be invited to participate.

Program Overview

Cirrhosis is a result of longstanding fibrosis, and can result in various negative sequelae including ascites. Ascites is the most common complication related to cirrhosis and is associated with increased morbidity and mortality. Refractory ascites occurs in approximately 5%-10% of all patients with cirrhosis and ascites and is associated with survival of only 50% at 6 months.

This online educational activity is designed to provide expert commentary on the pathophysiology and treatment of refractory ascites. These will be presented in a multimedia format, including audio interviews with an expert thought leader and animated videos integrated into text-based elements.

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Explain various factors that contribute to the pathophysiology of refractory ascites
• Formulate a treatment plan for patients with refractory ascites based on current evidence

Faculty

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible entities.

Elizabeth Verna, MD, MSc

• Grant/Research Support: Salix Pharmaceuticals

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

1. Complete the activity (including pre- and post-activity assessments).
2. Answer the evaluation questions.
3. Request credit using the drop-down menu.

You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.